Literature DB >> 3139930

Abetalipoproteinaemia in adults: role of vitamin therapy.

A J MacGilchrist1, P R Mills, M Noble, W S Foulds, J A Simpson, G Watkinson.   

Abstract

The retinal and neurological complications of abetalipoproteinaemia may be preventable by replacing vitamins A and E from an early age, but their role in adult presentations is less clear. Two adult females with abetalipoproteinaemia have received 8 and 10 years respectively of replacement therapy with vitamins A, E and linoleic acid. In Case 1, visual function improved objectively on commencing therapy but has subsequently deteriorated and her neuropathy has slowly progressed. The rate of progression of neurological impairment in Case 2 was slowed but not halted by therapy, and her severe visual disturbance was unaffected. Replacement by fat soluble vitamins has only a limited role in the management of abetalipoproteinaemia once irreversible neurological/retinal damage has occurred.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139930     DOI: 10.1007/bf01799870

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

1.  Malformation of the erythrocytes in a case of atypical retinitis pigmentosa.

Authors:  F A BASSEN; A L KORNZWEIG
Journal:  Blood       Date:  1950-04       Impact factor: 22.113

2.  Micromethod for tocopherol determination in blood serum.

Authors:  J Fabianek; J DeFilippi; T Richards; A Herp
Journal:  Clin Chem       Date:  1968-05       Impact factor: 8.327

3.  Vitamin A and vitamin E replacement in abetalipoproteinemia.

Authors:  J G Bieri; J M Hoeg; E J Schaefer; L A Zech; H B Brewer
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

4.  Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia.

Authors:  D P Muller; J K Lloyd
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  The biochemical modes of action of vitamin e and selenium: A hypothesis.

Authors:  A T. Diplock; J A. Lucy
Journal:  FEBS Lett       Date:  1973-02-01       Impact factor: 4.124

6.  Deficiencies of vitamins E and A in the rat. Retinal damage and lipofuscin accumulation.

Authors:  W G Robison; T Kuwabara; J G Bieri
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-09       Impact factor: 4.799

7.  Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia.

Authors:  S Bishara; S Merin; M Cooper; E Azizi; G Delpre; R J Deckelbaum
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

8.  Vitamin E and neurological function.

Authors:  D P Muller; J K Lloyd; O H Wolff
Journal:  Lancet       Date:  1983-01-29       Impact factor: 79.321

9.  The neuropathy of abetalipoproteinemia.

Authors:  R G Miller; C J Davis; D R Illingworth; W Bradley
Journal:  Neurology       Date:  1980-12       Impact factor: 9.910

10.  Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides.

Authors:  E Azizi; J L Zaidman; J Eshchar; A Szeinberg
Journal:  Acta Paediatr Scand       Date:  1978-11
View more
  3 in total

1.  Cerebellar Ataxia.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

2.  Therapeutic interventions in the primary hereditary ataxias.

Authors:  Gonzalo J Revuelta; George R Wilmot
Journal:  Curr Treat Options Neurol       Date:  2010-07       Impact factor: 3.598

3.  Large Benefit from Simple Things: High-Dose Vitamin A Improves RBP4-Related Retinal Dystrophy.

Authors:  Vasily M Smirnov; Baptiste Wilmet; Marco Nassisi; Christel Condroyer; Aline Antonio; Camille Andrieu; Céline Devisme; Serge Sancho; José-Alain Sahel; Christina Zeitz; Isabelle Audo
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.